Establishment of the Institut Pasteur-Oncovita joint laboratory

The aim of the joint laboratory, which will focus on immunotherapy in oncology and prophylactic vaccines, is to design and develop vaccine candidates through to proof of concept in humans.

Oncovita and the Institut Pasteur have already been working together for several years for the design and development of new vaccines using MeasovirR technology, based on the measles vaccine virus.

Find out more